Q4 2024 Holdings
Filed 2025-02-12 | 93 holdings | $276.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Calumet, Inc.(CLMT) | Common | 131428104 | $80.4M | 3,651,361 | 29.1% |
| Apollo Global Management, Inc.(APO) | Common | 03769M106 | $37.2M | 225,000 | 13.4% |
| Janus Henderson AAA CLO ETF(JAAA) | Common | 47103U845 | $29.9M | 590,397 | 10.8% |
| Alphabet Inc(GOOG) | Common | 02079K107 | $21.4M | 112,220 | 7.7% |
| DocGo, Inc.(DCGO) | Common | 256086109 | $13.0M | 3,070,850 | 4.7% |
| Janus Henderson AAA CLO ETF | Common | 471034845 | $8.0M | 157,932 | 2.9% |
| Verona Pharma Plc.(VRNA) | Common | 925050106 | $7.4M | 159,300 | 2.7% |
| Pfizer Inc.(PFE) | Common | 717081103 | $6.8M | 254,537 | 2.4% |
| The Invesco AAA Floating Rate Note ETF(ICLO) | Common | 46090A721 | $5.2M | 201,487 | 1.9% |
| JPMorgan Chase & Co.(JPM) | Common | 46625H100 | $5.0M | 20,985 | 1.8% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | Common | 14888U101 | $4.4M | 210,000 | 1.6% |
| Travere Therapeutics, Inc.(TVTX) | Common | 89422G107 | $4.0M | 228,000 | 1.4% |
| OmniAb Inc.(OABI) | Common | 68218J103 | $3.9M | 1,094,505 | 1.4% |
| Avadel Pharmaceuticals plc | Common | G29687103 | $3.6M | 346,904 | 1.3% |
| Xeris Biopharma Holdings, Inc.(XERS) | Common | 98422E103 | $3.4M | 1,000,000 | 1.2% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | Common | 09058V103 | $3.3M | 440,000 | 1.2% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $3.1M | 612,270 | 1.1% |
| Enstar Group Limited | Common | G3075P101 | $2.4M | 7,500 | 0.9% |
| Immunovant Inc.(IMVT) | Common | 45258J102 | $2.3M | 92,000 | 0.8% |
| CSX Corporation(CSX) | Common | 126408103 | $2.3M | 70,000 | 0.8% |
| Protagonist Therapeutics, Inc(PTGX) | Common | 74366E102 | $2.0M | 52,368 | 0.7% |
| Inozyme Pharma, Inc. | Common | 45790W108 | $1.9M | 695,000 | 0.7% |
| AllianceBernstein Holding L.P.(AB) | Common | 01881G106 | $1.8M | 48,000 | 0.6% |
| Syndax Pharmaceutical, Inc.(SNDX) | Common | 87164F105 | $1.7M | 128,000 | 0.6% |
| Viking Therapeutics, Inc.(VKTX) | Common | 92686J106 | $1.6M | 39,036 | 0.6% |
| The Panagram Bbb-B CLO ETF(CLOZ) | Common | 81752T528 | $1.3M | 47,807 | 0.5% |
| Ryman Hospitality Properties, Inc.(RHP) | Common | 78377T107 | $1.3M | 12,000 | 0.5% |
| Mereo BioPharm Group PLC(MREO) | Common | 589492107 | $1.2M | 331,000 | 0.4% |
| aTyr Pharma, Inc.(ATYR) | Common | 002120202 | $1.1M | 308,133 | 0.4% |
| Collegium Pharmaceutical, Inc.(COLL) | Common | 19459J104 | $943.4K | 32,927 | 0.3% |
| Spdr S&P Biotech ETF(XBI) | Common | 78464A870 | $900.6K | 10,000 | 0.3% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $895.1K | 5,037 | 0.3% |
| Xenon Pharmaceuticals Inc.(XENE) | Common | 98420N105 | $817.9K | 20,866 | 0.3% |
| Vertex Pharmaceuticals, Inc.(VRTX) | Common | 92532F100 | $805.4K | 2,000 | 0.3% |
| Kimberly-Clark Corporation(KMB) | Common | 494368103 | $786.2K | 6,000 | 0.3% |
| DuPont de Nemours, Inc.(DD) | Common | 26614N102 | $757.2K | 9,930 | 0.3% |
| Microsoft Corporation(MSFT) | Common | 594918104 | $674.4K | 1,600 | 0.2% |
| Corteva, Inc.(CTVA) | Common | 22052L104 | $658.6K | 11,563 | 0.2% |
| Medtronic, Inc.(MDT) | Common | G5960L103 | $639.0K | 8,000 | 0.2% |
| Evolus, Inc.(EOLS) | Common | 30052C107 | $635.6K | 57,570 | 0.2% |
| Apple Inc.(AAPL) | Common | 037833100 | $624.5K | 2,494 | 0.2% |
| MeiraGTx Holdings plc(MGTX) | Common | G59665102 | $579.0K | 95,080 | 0.2% |
| Mondelez International Inc.(MDLZ) | Common | 609207105 | $537.6K | 9,000 | 0.2% |
| Cybin Inc(HELP) | Common | 23256X407 | $533.1K | 60,446 | 0.2% |
| Canadian Natural Resources Limited(CNQ) | Common | 136385101 | $518.6K | 16,800 | 0.2% |
| Xoma Corporation(XOMA) | Common | 98419J206 | $518.3K | 19,722 | 0.2% |
| Viridian Therapeutics, Inc.(VRDN) | Common | 92790C104 | $479.3K | 25,000 | 0.2% |
| International Business Machines(IBM) | Common | 459200101 | $470.9K | 2,142 | 0.2% |
| BioMarin Phamaceutical Inc.(BMRN) | Common | 09061G101 | $381.2K | 5,800 | 0.1% |
| Eli Lilly & Co.(LLY) | Common | 532457108 | $231.6K | 300 | 0.1% |